Stocks Press Release .com

Activity

News

9 New Faculty Members Join PHBS

9 New Faculty Members Join PHBS

Geng Xiao received PhD in Economics from UCLA in 1991, he was a tenured faculty at the University of Hong Kong (HKU). For more than a decade, Xiao held senior positions of doing practical policy studies at think-tanks, financial institutions, regulatory agencies, and international organizations in Mainland China, Hong Kong and overseas. His research and practice focused on China’s economic reform and opening, covering macroeconomics, finance, enterprise reform, urban development, and U.S.-China relations and he has published extensively in both English and Chinese (including 7 indexed by SSCI).Xianhua Peng earned his PhD in operations research from Columbia University in 2009. Prior to... »

ClearStructure Financial Technology Versnelt Groei met het Openen van een nieuw Kantoor in Hyderabad, India

ClearStructure Financial Technology Versnelt Groei met het Openen van een nieuw Kantoor in Hyderabad, India

DANBURY, Connecticut, 26 september 2018 /PRNewswire/ — ClearStructure Financial Technology, een leidende leverancier van bekroonde portfolio managementoplossingen gebruikt door beleggingsbeheer professionelen en bedrijven waaronder hedgefondsen, traditionele vermogensbeheerders, particuliere instanties, particuliere schuldinstanties, administrators en CLO managers, kondigt vandaag de opening van een nieuw kantoor in Hyderabad, in India aan. De uitbreiding van ClearStructure in India bouwt aan zijn wereldwijd succes en maakt het voor het bedrijf mogelijk om zijn groeiende klantenlijst beter te bedienen. ” Sinds de opening van ons kantoor in New York eind 2017 hebben wij een stevig... »

TUV Rheinland Issues Its First UL9540 Certificate to Sungrow ST548KWH-250 ESS Solution for US C&I Market

TUV Rheinland Issues Its First UL9540 Certificate to Sungrow ST548KWH-250 ESS Solution for US C&I Market

As one of the world’s largest energy storage markets, North America holds the highest standards for the inverter and battery quality, more stringent safety requirements for the system. TUV Rheinland’s UL9540 evaluation tests are very comprehensive and strict, which cover battery, energy storage inverter, battery connection panel, switchgears, control system and other auxiliary components such as HVAC and fire suppression system. To meet the growing demand for C&I energy storage in North America, Sungrow designed this turnkey solution specifically for the US customers and made relentless tests including the shake and vibration test to meet California’s special installati... »

Abu Dhabi International Hunting and Equestrian Exhibition 2018 abre as portas hoje

Abu Dhabi International Hunting and Equestrian Exhibition 2018 abre as portas hoje

ABU DHABI, Emirados Árabes Unidos–(BUSINESS WIRE)–Com o patrocínio de Sua Alteza o Sheik Hamdan bin Zayed Al Nahyan, representante do Soberano na Região de Al Dhafra Region, presidente do conselho do Clube dos Falcoeiros dos Emirados, a 16 ª edição da Exposição Internacional de Equitação e Caça de Abu Dhabi (Abu Dhabi International Hunting and Equestrian Exhibition, ADIHEX) foi inaugurada no Abu Dhabi National Exhibition Center (ADNEC), que vai ocorrer até o dia 29 de setembro e comemora neste ano o centenário do Sheik Zayed. O evento é organizado pelo Clube dos Falcoeiros dos Emirados e é apoiado pela Agência ambiental de Abu Dhabi (Environment Agency – Abu Dhabi, EAD), Fu... »

Evolve Biologics™ Provides Update on Progress in Phase III Trial for PlasmaCap™ IG (Intravenous Immunoglobulin)

Evolve Biologics™ Provides Update on Progress in Phase III Trial for PlasmaCap™ IG (Intravenous Immunoglobulin)

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Evolve Biologics (“Evolve”), a division of Therapure Biopharma Inc. (“Therapure”) and an innovative developer of plasma-derived therapeutics, today provided an update on continued progress in its Phase III multicenter clinical trial of PlasmaCap™ IG (Intravenous Immunoglobulin or “IVIG”), an investigational IVIG replacement therapy being studied in both adult and pediatric patients with primary immune deficiency diseases (“PIDD”). The study received approval to proceed from the U.S. Food and Drug Administration (“FDA”) and Health Canada in summer 2017. PlasmaCap IG has been developed utilizing Evolve’s innovative PlasmaCap EBA™ technology, whi... »